Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Retina. 2016 Dec;36(Suppl 1):S147–S158. doi: 10.1097/IAE.0000000000001256

Table 1.

Summary of Demographic, Clinical and Genetic Data

Patient Eye Sex Age Ethnicity Inheritance BCVA OD
(Snellen)
BCVA OS
(Snellen)
Gene Mutation 1 Mutation 2 Mutation 3
1 OU F 15 Caucasian AR 20/20 20/20
2 OU F 28 Caucasian AR 20/20 20/20
3 OU F 54 Caucasian AR 20/20 20/20
4 OU M 21 Caucasian AR 20/40 20/40 USH2A p.T1238R p.C3153*
5 OD M 52 Caucasian AD 20/30 HM RHO D190N
6 OU F 25 Hispanic AR 20/25 20/30 CNGB1 p.F1051Lfs*12 p.F1051Lfs*12
7 OU F 53 Caucasian AR 20/30 20/50
8 OS M 37 Caucasian AD 20/50 20/25
9 OS M 7 Hispanic AR 20/50 20/30
10 OU F 11 Hispanic AR 20/25 20/25
11 OU M 59 Caucasian AD 20/25 20/25 RP1 c.2285_2289delTAAAT
12 OU M 50 Caucasian AD 20/20 20/20
13 OU M 22 Caucasian AR 20/25 20/20
14 OD M 32 Indian AR 20/30 20/20 KIAA1549 p.Y120A p.S642L
15 OD F 33 Caucasian AR 20/20 20/20
16 OU F 16 Caucasian AD 20/20 20/20 RHO c.937-27_-19delCCCTGACTC
17 OU M 20 Hispanic AR 20/25 20/25
18 OD F 31 Asian AD 20/20 20/20
19 OU M 33 Hispanic AR 20/20 20/20
20 OU F 32 Asian AR 20/25 20/20
21 OU M 56 Caucasian AD 20/20 20/25
22 OD M 21 Caucasian AR 20/25 20/40 GPR98 p.Q2301* p.Q2301*
23 OU M 68 Caucasian AR 20/20 20/20
24 OU M 38 Caucasian AD 20/20 20/20
25 OU M 29 Caucasian AD 20/20 20/25 RP1 p.R667*
26 OU F 18 Caucasian AD 20/25 20/25 PRPF31 p.L128*
27 OS F 38 Caucasian unknown 20/25 20/25
28 OU M 61 Caucasian AD 20/20 20/20
29 OU M 30 Caucasian XL 20/30 20/40 RPGR p.Q732RfsX83
30 OU M 13 Caucasian XL 20/30 20/30 RPGR p.G436D
31 OU M 14 Caucasian AD 20/30 20/40
32 OU M 22 Hispanic AR 20/25 20/25 CNGB1 p.F1051Lfs*12 p.F1051Lfs*12
33 OU M 57 Caucasian AR 20/25 20/50 USH2A
34 OU M 64 Caucasian unknown 20/20 20/20
35 OU M 51 Asian AR 20/20 20/20 EYS p.L2671Y p.C2139Y p.S547Rfs
36 OU F 31 Caucasian AR 20/40 20/40 RGR p.S66R p.S66R
37 OU F 57 Caucasian AR 20/20 20/20
38 OU M 16 Indian XL 20/25 20/40 RPGR p.G68R
39 OU F 77 Caucasian AR 20/25 20/30
40 OD M 43 Caucasian AD 20/50 20/63
41 OU M 15 Caucasian AD 20/20 20/20
42 OU M 19 Caucasian AD 20/20 20/20
43 OU F 32 Asian AR 20/20 20/20
44 OU M 44 Hispanic XL 20/80 20/63 RPGR c.2236_2237delAG
45 OU M 30 Caucasian AR 20/30 20/25
46 OU M 37 Hispanic AR 20/50 20/40 PDE6A p.R102C p.S303C
47 OD F 11 African American AR 20/30 20/25
48 OD F 53 Caucasian AD 20/40 20/40 RP1L1 c.5334_5335delAC
49 OU M 75 Caucasian AD 20/50 20/40 RHO p.G106R
50 OU F 28 Caucasian AR 20/50 20/80 FAM161B p.V707YfsX9 *
51 OU F 35 Caucasian AD 20/30 20/25 KLHL7 p.N145Y
52 OU F 49 Caucasian AR 20/63 20/80
53 OU F 31 Caucasian unknown 20/20 20/20
54 OU M 46 Asian AR 20/50 20/20
55 OU F 19 Caucasian AR 20/25 20/25
56 OU F 43 Caucasian unknown 20/20 20/20
57 OU F 58 Caucasian AR 20/50 20/160
58 OU F 36 Caucasian AD 20/30 20/25 RHO p.R135I p.R135R
59 OU M 38 Caucasian unknown 20/40 20/40
60 OU M 43 Hispanic AD 20/50 20/20

BCVA, best corrected visual acuity; OD, right eye; OS, left eye; AD, autosomal dominant; AR, autosomal recessive: XL, X-linked,

*

indicates stop codon.

denotes sibling pair: P6 and P23

HHS Vulnerability Disclosure